Rhythm Pharmaceuticals Shows Market Leadership With Jump To 91 RS Rating

By Investor's Business Daily   |   2 months ago
Rhythm Pharmaceuticals Shows Market Leadership With Jump To 91 RS Rating

IBD's RS Rating measures market leadership by comparing a stock's price performance against others. Stocks with RS Rating above 80 at the start of a price run often become top winners.

Read More

Did you find this insightful?